Baxter International Inc. BAX
25.91 USD -0.43 (-1.65%)
Nov 12, 2026, 2:36 PM EST
25.87 Day range 26.66
15.73 52-week range 30.00
- YTD
- +35.56%
- 1 year
- +38.53%
News
benzinga.com Barclays Maintains Underweight on Baxter International, Raises Price Target to $23 Barclays analyst Christopher Pasquale maintains Baxter International (NYSE:BAX) with a Underweight and raises the price target from $20 to $23.
benzinga.com JP Morgan Maintains Neutral on Baxter International, Lowers Price Target to $25 JP Morgan analyst Robbie Marcus maintains Baxter International (NYSE:BAX) with a Neutral and lowers the price target from $26 to $25.
benzinga.com Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $25 Wells Fargo analyst Larry Biegelsen maintains Baxter International (NYSE:BAX) with a Equal-Weight and raises the price target from $23 to $25.
benzinga.com Why Is Baxter Stock Trading Lower on Thursday? Baxter tops Q3 consensus with 58 cents EPS and $2.976 billion in sales, lifting fiscal 2026 profit and revenue guidance above Wall Street forecasts.
benzinga.com Baxter Intl Q3 2026 Earnings Call Transcript Baxter Intl (NYSE:BAX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…- benzinga.com Baxter International Raises FY2026 Adj EPS Guidance from $1.95-$2.15 to $2.05-$2.15 vs $2.05 Est; Raises FY2026 Sales Guidance from $11.581B-$11.694B to $11.694B-$11.806B vs $11.619B Est Baxter International (NYSE:BAX) raises FY2026 Adj EPS guidance from $1.95-$2.15 to $2.05-$2.15 vs $2.05 analyst estimate. Raises FY2026 sales outlook from $11.581 billion-$11.694 billion to $11.694…
benzinga.com Top 3 Health Care Stocks That May Rocket Higher In September CVS, Steris and Baxter are oversold healthcare stocks with RSI readings near or below 30, potentially offering undervalued buying opportunities.
benzinga.com TD Cowen Maintains Hold on Baxter International, Raises Price Target to $29 TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $24 to $29.- benzinga.com Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $23 Wells Fargo analyst Larry Biegelsen maintains Baxter International (NYSE:BAX) with a Equal-Weight and raises the price target from $19 to $23.
benzinga.com Stifel Maintains Hold on Baxter International, Raises Price Target to $28 Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $24 to $28.- benzinga.com Citigroup Upgrades Baxter International to Neutral, Raises Price Target to $28 Citigroup analyst Joanne Wuensch upgrades Baxter International (NYSE:BAX) from Sell to Neutral and raises the price target from $17 to $28.
benzinga.com Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress Baxter stock climbs after second-quarter earnings and revenue topped estimates as the company raised fiscal 2026 sales and profit guidance.- benzinga.com Baxter International Raises FY2026 Adj EPS Guidance from $1.85-$2.05 to $1.95-$2.15 vs $1.91 Est; Raises FY2026 Sales Guidance from $11.244B-$11.356B to $11.581B-$11.694B vs $11.357B Est Baxter International (NYSE:BAX) raises FY2026 Adj EPS guidance from $1.85-$2.05 to $1.95-$2.15 vs $1.91 analyst estimate. Raises FY2026 sales outlook from $11.244 billion-$11.356 billion to $11.581…
benzinga.com Baxter Intl Q2 Adj. EPS $0.54 Beats $0.37 Estimate, Sales $2.960B Beat $2.795B Estimate Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.37 by 45.95 percent. This is a 8.47 percent decrease over earnings of $0.59 per…- benzinga.com UBS Maintains Neutral on Baxter International, Raises Price Target to $25 UBS analyst Patrick Wood maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $25.
benzinga.com Stifel Maintains Hold on Baxter International, Raises Price Target to $24 Stifel analyst Rick Wise maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $19 to $24.
benzinga.com TD Cowen Maintains Hold on Baxter International, Raises Price Target to $24 TD Cowen analyst Joshua Jennings maintains Baxter International (NYSE:BAX) with a Hold and raises the price target from $20 to $24.- benzinga.com Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21 Goldman Sachs analyst David Roman maintains Baxter International (NYSE:BAX) with a Neutral and raises the price target from $19 to $21.
- benzinga.com Evercore ISI Group Maintains Outperform on Baxter International, Raises Price Target to $24 Evercore ISI Group analyst Vijay Kumar maintains Baxter International (NYSE:BAX) with a Outperform and raises the price target from $22 to $24.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Earnings Scheduled For April 30, 2026 
benzinga.com Alpha Buying: Following Conviction, Not the Crowd 
benzinga.com EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks Oil prices have risen. Here's how Strait of Hormuz tensions could soon increase healthcare costs and make everyday medical supplies more expensive.
benzinga.com Cisco Triggers Tech Selloff, VIX Spikes 16%: What's Moving Markets Thursday? A volatile Thursday rattled Wall Street, with technology and software stocks sliding across the board after a cautious margin outlook from Cisco Systems Inc.- benzinga.com Earnings Scheduled For February 12, 2026
benzinga.com Earnings Scheduled For October 30, 2025 
benzinga.com S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon.
benzinga.com Novo Nordisk, United Parcel Service, And Moderna Are Among Top 10 Large Cap Losers Last Week (July 28-August 1): Are The Others In Your Portfolio? Ten large-cap stocks, including Novo Nordisk and UPS, tumbled last week on weak earnings and guidance cuts.
benzinga.com Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday? A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For July 31, 2025
benzinga.com Earnings Scheduled For May 1, 2025 
benzinga.com DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday - benzinga.com Earnings Scheduled For February 20, 2025
- benzinga.com Earnings Scheduled For February 13, 2025
benzinga.com Deal Dispatch: PharmChem Forgoes Banker To Run Sale, TGI Fridays Sells 19 Restaurants For $3.1 Million Bausch + Lomb's efforts to sell have so far been unsuccessful. Meanwhile, KKR is aggressively pursuing a deal for Fuji Soft.- benzinga.com Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
- benzinga.com AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- benzinga.com Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and…
- benzinga.com Why Are Dialysis Provider Stocks Trading Higher On Tuesday? Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks
- benzinga.com Earnings Scheduled For February 8, 2024 Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
- benzinga.com Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in…
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 647 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 386 stocks made new 52-week lows.
- benzinga.com Earnings Scheduled For July 27, 2023 Companies Reporting Before The Bell • SES AI (NYSE:SES) is projected to report quarterly earnings at $0.11 per share on revenue of $337.60 million.
- benzinga.com WHO Ends Global Emergency Status for COVID-19, Virgin Galactic Plans To Launch Space Tourism In Q2, Berkshire Hathaway Has No Intentions To Take Control Of Occidental Petroleum: Today's Top Stories Benzinga
- benzinga.com Earnings Scheduled For April 27, 2023 Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023 - benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 497 companies set new 52-week lows.